CN106421639A - Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases - Google Patents
Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases Download PDFInfo
- Publication number
- CN106421639A CN106421639A CN201610889297.0A CN201610889297A CN106421639A CN 106421639 A CN106421639 A CN 106421639A CN 201610889297 A CN201610889297 A CN 201610889297A CN 106421639 A CN106421639 A CN 106421639A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- blood
- cardiovascular
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases. The traditional Chinese medicine is prepared from radix angelicae sinensis, radix paeoniae rubra, rhizoma ligustici wallichii, dried rehmannia root, cattail pollen, radix salviae miltiorrhizae, radix aucklandiae, fructus aurantii immaturus, turtle shell, tortoise shell, radix scutellariae, herba taraxaci, honeysuckle flowers, rhizoma alismatis, rhizoma sparganii, rhizoma curcumae and liquorice root. The traditional Chinese medicine provided by the invention, in accordance with the pathogenesis of the diseases (cardiovascular and cerebrovascular diseases) which are caused by brain hemorrhagic or ischemic injury induced by narrowing of blood vessels, insufficient blood supply or cerebral vascular thrombosis when cardiovascular or cerebrovascular atherosclerosis occurs, so that in order to treat the diseases, it needs to adopt such means as promoting blood circulation and removing stasis, resisting thrombosis and dissolving fat, softening blood vessels and the like to improve cardiovascular and cerebrovascular angiospasm and stiffness, reduce cholesterol in blood, block off the thrombosis, dilate coronary arteries and increase a blood flow volume; therefore, a radical cure effect of treating both symptoms and root causes and reducing a recurrence rate is achieved.
Description
Technical field
The present invention relates to a kind of Chinese medicine, more particularly to a kind for the treatment of cardiovascular and cerebrovascular disease prepared for raw material with Chinese herbal medicine
The Chinese medicine of disease.
Background technology
Cardiovascular and cerebrovascular disease is the general name of two big class diseases, and it can be divided into angiocardiopathy and cranial vascular disease.Cardiovascular
Based on coronary heart disease, coronary heart disease, also known as coronary arteriosclerotic cardiopathy, is the coronary artery due to supplying myocardial blood to disease
Occur atherosis, so that arteries is narrowed, deficiency myocardial blood supply causes；Due to coronary artery pathological changes cause luminal stenosis or
Inaccessible clinical symptoms, are not quite similar in time length, degree weight, therefore can behave as recessive heart disease, angina pectoris, the heart
The various ways such as muscle infarction, myocardiosclerosis and sudden cardiac death.Cerebrovascular disease then refers to rupture of blood vessel in brain bleeding or thrombosis,
The one group of disease with cerebral haemorrhage or ischemia injury symptom as main clinical manifestation causing, is commonly called as headstroke；This disease
It is common in the acute attack of crowd above middle age, severe patient can occur the disturbance of consciousness and quadriplegia, be to cause the mankind dead at present
Die and disabled principal disease.At present in terms for the treatment of cardiovascular and cerebrovascular disease, typically based on Western medicine, its side effect is larger, contains
Chemical composition is more, have even using the therapeutic scheme taking hormones, frequently result in the appearance of complication.In middle treatment
Treatment aspect, the method frequently with taking decoction of medicinal ingredients, uncertain therapeutic efficacy is cut, and inconvenience is administered orally, not portable.Although many is occurred on market control
Treat the Chinese patent drug of cardiovascular and cerebrovascular disease, therapeutic effect is also undesirable, and expense is also than larger.
Content of the invention
The purpose of the present invention is to overcome prior art not enough, and provide that a kind of curative effect is fast, expense is low, controlling of having no toxic side effect
Treat the Chinese medicine of cardiovascular and cerebrovascular disease.
For realizing the purpose of the present invention, now depending on following technical scheme.This medicine is by following weight
Raw material is made：
25 35 parts of Radix Angelicae Sinensis, 15 25 parts of the radix paeoniae rubrathe, 15 25 parts of Ligusticum wallichii, 35 45 parts of the dried rhizome of rehmannia, 10 15 parts of cattail pollen, the red sage root 20
25 parts, 20 25 parts of the banksia rose, 20 30 parts of the dried immature fruit of citron orange, 10 15 parts of turtle shell, 10 15 parts of tortoise plastron, 15 25 parts of the root of large-flowered skullcap, dandelion
15 25 parts, 15 25 parts of honeysuckle, 15 25 parts of rhizoma alismatis, 15 25 parts of Rhizoma Sparganii, 15 25 parts of curcuma zedoary, 10 20 parts of Radix Glycyrrhizae.
The Chinese medicine of the present invention according to this sick pathogenesis be due to be due to the heart, the cerebrovascular occur atherosis, make blood
Pipe narrows, blood supply insufficiency, or cerebrovascular thrombosis, and cause is caused with cerebral haemorrhage or ischemia injury, therefore controls
Treat this disease and cardiovascular and cerebrovascular spasm, stiff situation must be improved using the method such as promoting blood circulation and removing blood stasis, anti-bolt fat melting, softening blood vessel, reduce
Blood cholesterol levels, block thrombosis, coronary artery dilator, increase CBF, reach the radical cure effect of recurrence for the treatment of both principal and secondary aspect of disease, be difficult
Really.
Fang Xie：
Radix Angelicae Sinensis：Replenishing and activating blood, menstruction regulating and pain relieving, relax bowel.For blood deficiency chlorosis, dizziness palpitaition, irregular menstruation, closed dysmenorrhea,
Asthenia cold abdominalgia, dry constipation of intestines, arthralgia due to wind-dampness, injury from falling down, ulcer sores.
The radix paeoniae rubrathe：Bitter, cold nature.Return liver warp.There is the function of clearing heat and cooling blood, blood stasis removing analgesic.
Ligusticum wallichii：Taste is pungent, warm in nature.Return liver, courage, pericardium channel.Blood-activating and qi-promoting, wind-expelling pain-stopping.
The dried rhizome of rehmannia：Clearing heat and promoting fluid, cool blood, hemostasis.For consumption of YIN caused by febrile disease, the deep red polydipsia of tongue, spot dermexanthesis, spit blood, bleeding from five sense organs or subcutaneous tissue, throat
Swell and ache.
Cattail pollen：Hemostasis, stagnation resolvation, treating stranguria.For spitting blood, bleeding from five sense organs or subcutaneous tissue, spitting of blood, uterine bleeding, traumatism and bleeding, closed dysmenorrhea, gastral cavity abdomen is pierced
Bitterly, tumbling and swelling, blood strangury and dry pain.
The red sage root：Promoting blood circulation for regulating menstruation, stasis-dispelling and pain-killing, cool blood to disappear carbuncle, relieving restlessness that clears away heart-fire, nourishing blood and tranquilization.
The banksia rose：Promoting qi circulation and relieving pain；Lead stagnant in tune.
The dried immature fruit of citron orange：Control internal stagnation；Feeling of fullness distending pain；Constipation；Weight after rush down dysentery；Accumulation of pathogens in chest；Gastroptosis；The prolapse of uterus；Prolapse of the anus.
Turtle shell：Nourshing kidney checking exuberance of yang, softening and resolving hard mass.
Tortoise plastron：Nourishing and suppressing Yang, the strong bone of kidney-nourishing, blood-nourishing bushing.For deficiency of Yin hectic fever, hectic fever due to yin night sweat, have a dizzy spell, in empty wind
Dynamic, muscles and bones impotence, have a guilty conscience forgetful.
The root of large-flowered skullcap：Heat-clearing and damp-drying drug, purging intense heat and detonicating, hemostasis, antiabortive, hypotensive.For damp-warm syndrome, heat temperature evil of vomitting uncomfortable in chest, damp and hot ruffian
Full, rush down dysentery, jaundice, cough with lung heat, hyperpyrexia polydipsia, blood-head tells nosebleed, carbuncle sore tumefacting virus, fetal irritability.
Dandelion：Sweet, slight bitter, tremble with fear.Clearing heat and detoxicating, dispersing swelling and dissipating binds.
Honeysuckle：There is clearing heat and detoxicating, dispelling wind and heat from the body effect.
Rhizoma Sparganii：Bitter, mild-natured.Blood-breaking, promoting the circulation of qi, Xiao Ji Zhi Tong.
Curcuma zedoary：Can gas consumption product pain relieving, vexed have a pain for eating accumulation, chest and abdomen are full.
Radix Glycyrrhizae：：Invigorate the spleen and benefit qi, clearing heat and detoxicating, expelling phlegm and arresting coughing, relieving spasm to stop pain, coordinating the drug actions of a prescription.
The Chinese medicine of the treatment cardiovascular and cerebrovascular disease of the present invention, preparation method is as follows：
Weigh above-mentioned each Chinese medicine by prescription, then pulverized 150 mesh sieves with pulverizer, mixing rear flashing is ball, such as mung bean
Greatly.It is medicine of the present invention.
The present invention be inventor on the basis of secret prescription handed down in the family from generation to generation, in conjunction with the summary of oneself clinical experience for many years, through repeatedly
Test and obtain, therefore this medicine has the curative effect of uniqueness to intractable cardiovascular and cerebrovascular disease, it adopts multiple medicines scientific compatibility, comprehensive measure
Make the effective ingredient of medicine quickly enter blood circulation, reduce blood cholesterol levels, block thrombosis, coronary artery dilator, increase
Heal flow, improve the tolerance of myocardial ischemia, improve cerebral infarction, repair impaired cranial nerve, make cardiovascular and cerebrovascular disease quickly
Rehabilitate.Medicine of the present invention to hypertension, high fat of blood, diabetes, encephalatrophy, cerebral thrombus, coronary heart disease, cerebral arteriovenous malformation, in
Wind sequelae has the curative effect of uniqueness.And have the advantages that instant effect, short treating period, cure rate height, expense are little.
Specific embodiment
Weigh raw material in following ratio：
25 35 parts of Radix Angelicae Sinensis, 15 25 parts of the radix paeoniae rubrathe, 15 25 parts of Ligusticum wallichii, 35 45 parts of the dried rhizome of rehmannia, 10 15 parts of cattail pollen, the red sage root 20
25 parts, 20 25 parts of the banksia rose, 20 30 parts of the dried immature fruit of citron orange, 10 15 parts of turtle shell, 10 15 parts of tortoise plastron, 15 25 parts of the root of large-flowered skullcap, dandelion
15 25 parts, 15 25 parts of honeysuckle, 15 25 parts of rhizoma alismatis, 15 25 parts of Rhizoma Sparganii, 15 25 parts of curcuma zedoary, 10 20 parts of Radix Glycyrrhizae.
The Chinese medicine of the treatment cardiovascular and cerebrovascular disease of the present invention, preparation method is as follows：Weigh above-mentioned each Chinese medicine by prescription, then
Pulverized 150 mesh sieves with pulverizer, mixing rear flashing is ball, as big in mung bean.It is medicine of the present invention.
The drug administration method of the present invention is：Oral, 2 times a day, before meals with warm water delivery service, 5 10 grams every time, and one
The moon is a course for the treatment of.
For showing the therapeutic effect to cardiovascular and cerebrovascular disease for the medicine of the present invention, the present inventor is clinical to 200 cases to be seen
Examine, wherein the male sex 150 people, women 50 people, 40 years old age -- 80 years old, course of disease 2--5, wherein hypertension 45, high fat of blood 70
Example, cerebral arteriovenous malformation 50, coronary heart disease 35.By taking the medicine of the present invention, general 1---6 course for the treatment of of medication, 185 rule by men
More, cure rate reaches 92%, and effectively, efficient be 98% to 196 people.
Typical clinical case
Case 1, Chen Zuqing, man, 65 years old, Zhengzhou City Jinshui District retired cadre, in October, 2006 suffers from cerebral infarction, controls through multiple hospitals
Treat, the cardiovascular and cerebrovascular diseases medicine dedicated such as informal dress thrombus-eliminating pills, cerebral ischemic, still leave sequelae in January, 2007, left side half body is not
Then, hypertension, palpitaition, cardiac arrhythmia, can't take care of oneself.Through the research of expert group of institute of traditional Chinese medicine of Zhoukou City, allow and take medicine of the present invention,
Blood pressure stabilization after three courses for the treatment of, can take part in the work, health is normal so far.
Case 2, Wang Qingju, man, 66 years old, people from Zhoukou City, it is diagnosed as high fat of blood and coronary heart disease through multiple hospitals, take daily
The cardiovascular and cerebrovascular disease medicines such as Danshen Tablets, brain blood lead to, suxiao jiuxin pills, do not feel any better, and prepare to make cardiac stent operation, through in Henan
Hospital expert recommends to take medicine of the present invention, heart pain, alleviation uncomfortable in chest in second day, and 15 day, day blood pressures are steady, after two months
Examination in hospital, blood fat index is normal, clinical cure after three months.
Case 3, Wang, female, 47 years old, Luoyang City grade teacher, suffer from hypertension, high fat of blood, hyperglycaemia, repeatedly go Beijing,
The large hospitals such as Shanghai are treated, still blood pressure 180,120, leg pain numbness, take after medicine of the present invention the through the big recommendation of Shanghai medical courses in general
Steadily, blood sugar declines two weeks blood pressures, and both legs pain disappears, and continuously takes above-mentioned disease recovery from illness after three courses for the treatment of.
Claims (2)
1. a kind of Chinese medicine treating cardiovascular and cerebrovascular disease is it is characterised in that it is made up of the Chinese medicine material of following weight proportion：
25 35 parts of Radix Angelicae Sinensis, 15 25 parts of the radix paeoniae rubrathe, 15 25 parts of Ligusticum wallichii, 35 45 parts of the dried rhizome of rehmannia, 10 15 parts of cattail pollen, the red sage root 20
25 parts, 20 25 parts of the banksia rose, 20 30 parts of the dried immature fruit of citron orange, 10 15 parts of turtle shell, 10 15 parts of tortoise plastron, 15 25 parts of the root of large-flowered skullcap, dandelion
15 25 parts, 15 25 parts of honeysuckle, 15 25 parts of rhizoma alismatis, 15 25 parts of Rhizoma Sparganii, 15 25 parts of curcuma zedoary, 10 20 parts of Radix Glycyrrhizae.
2. a kind of Chinese medicine treating cardiovascular and cerebrovascular disease according to claim 1 preparation method it is characterised in that：By group
Side weighs above-mentioned each Chinese medicine, then pulverizes 150 mesh sieves with pulverizer, and mixing rear flashing is ball, and such as mung bean is big, as originally
Invention medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610889297.0A CN106421639A (en) | 2016-10-12 | 2016-10-12 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610889297.0A CN106421639A (en) | 2016-10-12 | 2016-10-12 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106421639A true CN106421639A (en) | 2017-02-22 |
Family
ID=58173391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610889297.0A Pending CN106421639A (en) | 2016-10-12 | 2016-10-12 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106421639A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107158313A (en) * | 2017-04-28 | 2017-09-15 | 河南中医药大学第附属医院 | A kind of medicine for preventing and treating cardiovascular and cerebrovascular and preparation method thereof |
| CN110193059A (en) * | 2019-07-02 | 2019-09-03 | 河北唐威药业有限公司 | Novel thrombus-resisting capsules and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101091715A (en) * | 2007-07-10 | 2007-12-26 | 贵州信邦远东药业有限公司 | Composition of medication for treating cardiovascular diseases and cerebrovascular diseases |
| CN101716242A (en) * | 2010-01-11 | 2010-06-02 | 刘海涛 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
| CN104888150A (en) * | 2015-07-01 | 2015-09-09 | 华新宇 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
-
2016
- 2016-10-12 CN CN201610889297.0A patent/CN106421639A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101091715A (en) * | 2007-07-10 | 2007-12-26 | 贵州信邦远东药业有限公司 | Composition of medication for treating cardiovascular diseases and cerebrovascular diseases |
| CN101716242A (en) * | 2010-01-11 | 2010-06-02 | 刘海涛 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
| CN104888150A (en) * | 2015-07-01 | 2015-09-09 | 华新宇 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107158313A (en) * | 2017-04-28 | 2017-09-15 | 河南中医药大学第附属医院 | A kind of medicine for preventing and treating cardiovascular and cerebrovascular and preparation method thereof |
| CN110193059A (en) * | 2019-07-02 | 2019-09-03 | 河北唐威药业有限公司 | Novel thrombus-resisting capsules and preparation method thereof |
| CN114344424A (en) * | 2019-07-02 | 2022-04-15 | 河北唐威药业有限公司 | Novel antithrombotic capsule and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105250723A (en) | Medicine for treating diabetes | |
| CN101716242B (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases | |
| CN102274464B (en) | Chinese medicinal composition for treating chronic hepatitis, splenauxe and cirrhosis | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN102488875B (en) | Traditional Chinese medicine for treating acquired dysmenorrhea | |
| CN103638451A (en) | Traditional Chinese medicine for treating chronic hepatitis and preparation method thereof | |
| CN101204481A (en) | Chinese traditional medicine for chronic nephritis | |
| CN102847074B (en) | Blood stasis removing pill for treating ankylosing spondylitis | |
| CN101239151B (en) | Chinese medicine for preventing and controlling cardiovascular and cerebrovascular diseases and preparation method thereof | |
| CN100512852C (en) | Composite Chinese medicine took orally for treating coronary heart disease | |
| CN106421639A (en) | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases | |
| CN101337017A (en) | Medicine for treating coronary disease | |
| CN101496892B (en) | Oral Chinese patent medicine for treating cardiovascular disease | |
| CN101554471B (en) | Traditional Chinese medicine preparation for treating myocardial infarction | |
| CN103860773A (en) | Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof | |
| CN106267098A (en) | A kind of can effective Chinese medicine composition treating gout and preparation method thereof | |
| CN103212041B (en) | Chinese medicinal composition treating coronary heart disease | |
| CN103285328B (en) | Traditional Chinese medicine composition capsule for treating coronary heart diseases and preparation method thereof | |
| CN101391078B (en) | Internal medicine for treating fatty liver | |
| CN105169279A (en) | Traditional Chinese medicine composition for treating knee joint bone hyperplasia | |
| CN104800772A (en) | Traditional Chinese medicine composition for treating vital-energy-depression type coronary heart disease and application of traditional Chinese medicine composition | |
| CN104758439A (en) | Traditional Chinese medicine composition for treating thoracic obstruction | |
| CN104117018A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN104173494B (en) | A kind of Chinese medicine preparation treating coronary heart disease | |
| CN107158313A (en) | A kind of medicine for preventing and treating cardiovascular and cerebrovascular and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170222 |
|
| RJ01 | Rejection of invention patent application after publication |